What it is
5-Amino-1MQ is commonly discussed as a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). It is not a peptide and requires an exact chemical identity record.
Mechanism and research questions
- NNMT inhibition is the proposed research mechanism.
- Mechanistic rationale does not establish human efficacy or safety.
Human evidence
No robust human clinical evidence was identified in the initial source audit.
Preclinical / mechanistic evidence
The compound is discussed in preclinical NNMT and metabolic research, but claims should be tied to exact chemical records.
Evidence summary
The exact query returned no PubMed records in the initial audit; source quality and chemical identity need additional review.
Limits and interpretation
- Not a peptide; keep it in a separate compound class.
- Require CAS, structure, and analytical identity before expanding claims.
- No dosing or human-use guidance is provided.
Regulatory and identity note
Research small molecule; not presented as an approved medicine.